Elanco Animal Health Incorporated announced the U.S. Food and Drug Administration has approved Zenreli, a highly effective and convenient once-daily oral JAK inhibitor for control of itching associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.